Skip to main content
HistoAtlas

ARID1A Mutation in Ovarian Serous Cystadenocarcinoma

Tumor Suppressor

ARID1A mutations occur in approximately 6% of Ovarian Serous Cystadenocarcinoma cases. Explore survival impact, morphological differences, and co-occurring mutations below.

ARID1A in Other Cancer Types

Uterine Corpus Endometrial Carcinoma 44% Stomach Adenocarcinoma 24% Bladder Urothelial Carcinoma 24% Colon Adenocarcinoma 13% Cholangiocarcinoma 11% Uterine Carcinosarcoma 9% Liver Hepatocellular Carcinoma 8% Esophageal Carcinoma 7% Rectum Adenocarcinoma 6% Cervical Squamous Cell Carcinoma 6% Lung Squamous Cell Carcinoma 6% Lung Adenocarcinoma 5%

Other Mutations in Ovarian Serous Cystadenocarcinoma

TP53 92%

Explore Further

Ovarian Serous Cystadenocarcinoma Atlas ARID1A Pan-Cancer Overview All Mutations